inVentiv Clinical Trial Recruitment Solutions (iCTRS) has formed a strategic partnership with ViS Research to speed up the the antiquated system of clinical trial site evaluation. Under the partnership agreement, iCTRS and ViS will co-develop advanced, proprietary features for ViS' research platform that include automation of the Confidential Disclosure Agreement workflow and final sign-off, and enhanced analytical capabilities to rapidly compare feasibility information between sites.
The partnership is intended to give trial planners adequate analytics about research centers and locations where centers operate. ViS' platform will allow iCTRS to bring an interactive navigation system to the clinical research space, so that trial planners can match their needs with the disease-specific capabilities of individual research centers.
"We are committed to accelerating clinical research through breakthrough innovation, and this partnership offers trial sponsors the fastest most sophisticated way of ensuring research sites are properly equipped, staffed and ready to be processed for rapid activation," says Ramita Tandon, senior vice president and general manager for iCTRS. "We are looking forward to building on the remarkable platform and database that ViS already has created."
"The entire feasibility process has needed revamping, and in partnering with iCTRS we expand our ability to deliver greater efficiency to the industry through innovative technologies in analysis, visualization, and networking," said Fabio Thiers, MD, PhD, ViS founder and CEO, a Harvard/MIT physician-scientist and pioneer in clinical research analytics. "We believe the use of these technologies could reduce waste in global clinical research by 10-15%."
inVentiv Partners with ViS Research
By Gil Roth
Published September 18, 2013
blog comments powered by Disqus